According to a previous report, the reason for the poor prognosis associated with bone metastasis in patients with advanced EGFR‐positive NSCLC is the presence, at a high frequency (72.7%), of multiple (three or more) distant metastases in these patients [18]. The gene discussed is EGFR; the disease is bone metastasis.